Clinical significance of hepatitis C virus genotypes

Clinical Microbiology Reviews

Volumn 13, Issue 2, 2000, Pages 223-235

  Zein, Nizar N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS VACCINE; INTERFERON;

GENETIC EPIDEMIOLOGY; GENETIC HETEROGENEITY; GENETIC ORGANIZATION; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; REVIEW; VIRAL GENETICS; VIRUS CLASSIFICATION; VIRUS DIAGNOSIS;

ANTIVIRAL AGENTS; DISEASE PROGRESSION; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0034120427     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.13.2.223-235.2000     Document Type: Review

References (149)

1. Abdulkarim, A. S., N. N. Zein, J. J. Germer, C. P. Kolbert, L. Kabbani, K. L. Krajnik, A. Hola, M. N. Agha, M. Tourogman, and D. H. Persing. 1998. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am. J. Trop. Med. Hyg. 59:571-576.
2. Aizaki, H., A. Saito, I. Kusakawa, Y. Ashiwara, S. Nagamori, G. Toda, T. Suzuki, K. Ishii, Y. Matsuura, and T. Miyamura. 1996. Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region. J. Hepatol. 25:608-613.
3. Amoroso, P., M. Rapicetta, M. E. Tosti, A. Mele, E. Spada, S. Buonocore, G. Lettieri, P. Pierri, P. Chionne, A. R. Ciccaglione, and L. Sagliocca. 1998. Correlation between virus genotype and chronicity rate in acute hepatitis C. J. Hepatol. 28:939-944.
4. Beld, M., M. Penning, M. van Putten, A. van den Hoek, V. Lukashov, M. McMorrow, and J. Goudsmit. 1998. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies. J. Clin. Microbiol. 36:3002-3006.
5. Belli, L. S., E. Silini, A. Alberti, G. Bellati, C. Vai, E. Minola, G. Rondinara, L. de Carlis, M. Asti, D. Forti, and G. Ideo. 1996. Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation. Liver Transplant. Surg. 2:200-205.
6. Benvegnu, L., P. Pontisso, D. Cavalletto, F. Noventa, L. Chemello, and A. Alberti. 1997. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 25:211-215.
7. Berg, T., U. Hopf, K. Stark, R. Baumgarten, H. Lobeck, and E. Schreier. 1997. Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. J. Hepatol. 26:484-491.
8. Boker, K. H., G. Dalley, M. J. Bahr, H. Maschek, H. L. Tillmann, C. Trautwein, K. Oldhaver, U. Bode, R. Pichlmayr, and M. P. Manns. 1997. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 25:203-210.
9. Brechot, C. 1997. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma. Hepatology 25:772-774.
10. Bresters, D., H. T. Cuypers, H. W. Reesink, E. P. Mauser-Bunschoten, H. M. van den Berg, W. P. Schaasberg, J. C. Wilber, M. S. Urdea, P. Neuwald, and P. N. Lelie. 1994. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial. J. Med. Virol. 43:262-268.
11. Bronowicki, J. P., V. Venard, C. Botte, N. Monhoven, I. Gastin, L. Chone, H. Hudziak, B. Rhin, C. Delanoe, A. LeFaou, M. A. Bigard, and P. Gaucher. 1997. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N. Engl. J. Med. 337:237-240.
12. Bukh, J., R. H. Miller, and R. H. Purcell. 1995. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15:41-63.
13. Bukh, J., R. H. Purcell, and R. H. Miller. 1992. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc. Natl. Acad. Sci. USA 89:187-191.
14. Bukh, J., R. H. Purcell, and R. H. Miller. 1992. Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. USA 89:4942-4946.
15. Busch, M. P., J. C. Wilber, P. Johnson, L. Tobler, and C. S. Evans. 1992. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 32:420-425.
16. Causse, X., H. Godinot, M. Chevallier, P. Chossegros, F. Zoulim, D. Ouzan, J.-P. Heyraud, T. Fontanges, J. Albrecht, C. Meschievitz, and C. Trepo. 1991. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101:497-502.
17. Cha, T. A., E. Beall, B. Irvine, J. Kolberg, D. Chien, G. Kuo, and M. S. Urdea. 1992. At least five related, but distinct, hepatitis C viral genotypes exist. Proc. Natl. Acad. Sci. USA 89:7144-7148.
18. Chamberlain, R. W., N. Adams, A. A. Saeed, P. Simmonds, and R. M. Elliott. 1997. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J. Gen. Virol. 78: 1341-1347.
19. Chan, S. W., F. McOmish, E. C. Holmes, B. Dow, J. F. Peutherer, E. Follett, P. L. Yap, and P. Simmonds. 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73:1131-1141.
20. Charlton, M., E. Seaberg, R. Wiesner, J. Everhart, R. Zetterman, J. Lake, K. Detre, and J. Hoofnagle. 1998. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 28:823-830.
21. Chayama, K., M. Kobayashi, A. Tsubota, I. Koida. Y. Arase, S. Saitoh, K. Ikeda, and H. Kumada. 1995. Molecular analysis of intraspousal transmission of hepatitis C virus. J. Hepatol. 22:431-439.
22. Chen, P. J., M. H. Lin, K. F. Tai, P. C. Liu, C. J. Lin, and D. S. Chen. 1992. The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA. Virology 188:102-113.
23. Choo, Q. L., G. Kuo, R. Ralston, A. Weiner, D. Chien, G. Van Nest, J. Han, K. Berger, K. Thudium, C. Kuo, J. Kansopon, J. McFarland, A. Tabrizi, K. Ching, B. Moss, L. B. Cummins, M. Houghton, and E. Muchmore. 1994. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 91:1294-1298.
24. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
25. Choo, Q.-L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. J. Barr, A. J. Weiner, D. W. Bradley, G. Kuo, and M. Houghton. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
26. Cooreman, M. P., and E. M. Schoondermark-Van de Ven. 1996. Hepatitis C virus: biological and clinical consequences of genetic heterogeneity. Scand. J. Gastroenterol. Suppl. 218:106-115.
27. Crespo, J., B. Carte, J. L. Lozano, F. Casafont, M. Rivero, F. de la Cruz, and F. Pons-Romero. 1997. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia. Am. J. Gastroenterol. 92:1458-1462.
28. Davis, G. L., R. Esteban-Mur, V. Rustgi, J. Hoefs, S. C. Gordon, C. Trepo, M. L. Shiffman, S. Zeuzem, A. Craxi, M. H. Ling, and J. Albrecht for the International Hepatitis Interventional Therapy Group. 1998. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N. Engl. J. Med. 339:1493-1499.
29. Davis, G. L., and J. Y. Lau. 1997. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 26(Suppl. 1):122S-127S.
30. de Lamballerie, X., R. N. Charrel, H. Attoui, and P. De Micco. 1997. Classification of hepatitis C virus variants in six major types based on analysis of the envelope 1 and nonstructural 5B genome regions and complete polyprotein sequences. J. Gen. Virol. 78:45-51.
31. Delisse, A. M., M. Descurieux, T. Rutgers, E. D'Hondt, M. De Wilde, T. Arima, J. M. Barrera-Sala, M. G. Ercilla, J. L. Ruelle, and T. Cabezon. 1991. Sequence analysis of the putative structural genes of hepatitis C virus from Japanese and European origin. J. Hepatol. 13(Suppl. 4):S20-S23.
32. Detmer, J., R. Lagier, J. Flynn, C. Zayati, J. Kolberg, M. Collins, M. Urdea, and R. Sanchez-Pescador. 1996. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J. Clin. Microbiol. 34:901-907.
33. Di Bisceglie, A. M., Z. D. Goodman, K. G. Ishak, J. H. Hoofnagle, J. J. Melpolder, and H. J. Alter. 1991. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14:969-974.
34. Dixit, V., S. Quan, P. Martin, D. Larson, M. Brezina, R. DiNello, K. Sra, J. Y. Lau, D. Chien, J. Kolberg, A. Tagger, G. Davis, A. Polito, and G. Gitnick. 1995. Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J. Clin. Microbiol. 33:2978-2983.
35. Dusheiko, G., H. Schmilovitz-Weiss, D. Brown, F. McOmish, P. L. Yap, S. Sherlock, N. McIntyre, and P. Simmonds. 1994. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19:13-18.
36. Duverlie, G., H. Khorsi, S. Castelain, O. Jaillon, J. Izopet, F. Lunel, F. Eb, F. Penin, and C. Wychowski. 1998. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to Interferon sensitivity. J. Gen. Virol. 79:1373-1381.
37. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, N. Izumi, F. Marumo, and C. Sato. 1995. Comparison of full-length sequences of Interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Investig. 96:224-230.
38. Enomoto, N., A. Takada, T. Nakao, and T. Date. 1990. There are two major types of hepatitis C virus in Japan. Biochem. Biophys. Res. Commun. 170:1021-1025.
39. Esteban, J. I., R. Esteban, L. Viladomiu, J. C. López-Talavera, A. González, J. M. Hernández, M. Roget, V. Vargas, J. Genescà, M. Buti, J. Guardia, M. Houghton, Q.-L. Choo, and G. Kuo. 1989. Hepatitis C virus antibodies among risk groups in Spain. Lancet ii:294-297.
40. Everhart, J. E., A. M. Di Bisceglie, L. M. Murray, H. J. Alter, J. J. Melpolder, G. Kuo, and J. H. Hoofnagle. 1990. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann. Intern. Med. 112:544-545.
41. Farci, P., H. J. Alter, D. C. Wong, R. H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R. H. Purcell. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 91:7792-7796.
42. Reference deleted.
43. Reference deleted.
44. Gish, R. G., K. P. Qian, S. Quan, Y. L. Xu, I. Pike, A. Polito, R. DiNello, and J. Y. Lau. 1997. Concordance between hepatitis C virus serotyping assays. J. Viral Hepatol. 4:421-422.
45. Gordon, F. D., J. J. Poterucha, J. Germer, N. N. Zein, K. P. Batts, J. B. Gross, Jr., R. Wiesner, and D. Persing. 1997. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 63:1419-1423.
46. Gretch, D., W. Lee, and L. Corey. 1992. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J. Clin. Microbiol. 30:2145-2149.
47. Reference deleted.
48. Han, C. J., H. S. Lee, H. S. Kim, J. H. Choe, and C. Y. Kim. 1997. Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases. Korean J. Intern. Med. 12:21-27.
49. Han, J. H., V. Shyamala, K. H. Richman, M. J. Brauer, B. Irvine, M. S. Urdea, P. Tekamp-Olson, G. Kuo, Q. L. Choo, and M. Houghton. 1991. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc. Natl. Acad. Sci. USA 88:1711-1715.
50. Hawkins, A., F. Davidson, and P. Simmonds. 1997. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J. Clin. Microbiol. 35:187-192.
51. Healey, C. J., D. B. Smith, J. L. Walker, E. C. Holmes, K. A. Fleming, R. W. Chapman, and P. Simmonds. 1995. Acute hepatitis C infection after sexual exposure. Gut 36:148-150.
52. Hijikata, M., N. Kato, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, and K. Shimotohno. 1991. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem. Biophys. Res. Commun. 175:220-228.
53. Hofgartner, W. T., S. J. Polyak, D. G. Sullivan, R. L. Carithers, Jr., and D. R. Gretch. 1997. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J. Med. Virol. 53:118-126.
54. Hohne, M., E. Schreier, and M. Raggendorf. 1994. Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch. Virol. 137:25-34.
55. Hopf, U., B. Moller, D. Kuther, R. Stemerowicz, H. Lobeck, A. LudtkeHandjery, E. Walter, H. E. Blum, M. Roggendorf, and F. Deinhardt. 1990. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J. Hepatol. 10:69-76.
56. Reference deleted.
57. Kao, J. H., M. Y. Lai, Y. T. Hwang, P. M. Yang, P. J. Chen, J. C. Sheu, T. H. Wang, H. C. Hsu, and D. S. Chen. 1996. Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay. A clinicopathologic study and demonstration of the usefulness of a third-generation assay. Dig. Dis. Sci. 41:161-165.
58. Karino, Y., T. Matsushima, A. Saga, M. Tsuyuguchi, T. Miyazaki, and J. Toyota. 1991. Treatment of chronic non-A, non-B hepatitis with interferon. Gastroenterol. Jpn. 26(Suppl. 3):234-238.
59. Kato, N., M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, and K. Shimotohno. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA 87:9524-9528.
60. Kato, N., Y. Ootsuyama, S. Ohkoshi, T. Nakazawa, S. Mori, M. Hujikata, and K. Shimotohno. 1991. Distribution of plural HCV types in Japan. Biochem. Biophys. Res. Commun. 181:279-285.
61. Koda, T., M. Yonaha, A. Hayashi, and K. Ishikawa. 1996. Hepatitis C transmission between spouses. J. Gastroenterol. Hepatol. 11:1001-1005.
62. Koziel, M. J. 1996. Immunology of viral hepatitis. Am. J. Med. 100:98-109.
63. Koziel, M. J., D. Dudley, N. Afdhal, Q. L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
64. Koziel, M. J., D. Dudley, J. T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B. D. Walker. 1992. Intrahepalic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344.
65. Kuo, G., Q.-L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, G. E. Tegtmeier, F. Bonino, M. Colombo, W.-S. Lee, C. Kuo, K. Berger, J. R. Shuster, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
66. Lai, M. E., A. P. Mazzoleni, F. Argiolu, S. De Virgilis, A. Balestrieri, R. H. Purcell, A. Cao, and P. Farci. 1994. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388-390.
67. Lau, J. Y., G. L. Davis, L. E. Prescott, G. Maertens, K. L. Lindsay, K. Qian, M. Mizokami, P. Simmonds, and the Hepatitis Interventional Therapy Group. 1996. Distribution of hepatilis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann. Intern. Med. 124:868-876.
68. Li, J. S., S. P. Tong, L. Vitvitski, D. Lepot, and C. Trepo. 1991. Evidence of two major genotypes of hepatitis C virus in France and close relatedness of the predominant one with the prototype virus. J. Hepatol. 13(Suppl. 4): S33-S37.
69. Li, J. S., S. P. Tong, L. Vitvitski, D. Lepot, and C. Trepo. 1991. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene 105:167-172.
70. Li, J. S., L. Vitvitski, S. P. Tong, and C. Trepo. 1994. Identification of the third major genotype of hepatitis C virus in France. Biochem. Biophys. Res. Commun. 199:1474-1481.
71. Lin, R., M. N. Schoeman, P. I. Craig, M. Bilous, J. Grierson, J. A. McDonald, R. G. Batey, and G. C. Farrell. 1991. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C? Aust. N. Z. J. Med. 21:387-392.
72. Lopez-Labrador, F. X., S. Ampurdanes, X. Forns, A. Castells, J. C. Saiz, J. Costa, J. Bruix, J. M. Sanchez Tapias, M. T. Jimenez de Anta, and J. Rodes. 1997. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J. Hepatol. 27:959-965.
73. Lu, R. H., S. J. Hwang, C. Y. Chan, F. Y. Chang, and S. D. Lee. 1998. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay. J. Clin. Lab. Anal. 12:121-125.
74. Machida, A., H. Ohnuma, F. Tsuda, E. Munekata, T. Tanaka, Y. Akahane, H. Okamoto, and S. Mishiro. 1992. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology 16:886-891.
75. Maertens, G., and L. Stuyver. 1997. Genotypes and genetic variation of hepatitis C virus, p. 182-233. In T. J. Harrison and A. J. Zuckerman (ed.), The molecular medicine of viral hepatitis. John Wiley & Sons, Ltd., Chichester, England.
76. Maggi, F., M. L. Vatteroni, M. Pistello, C. M. Avio, N. Cecconi, F. Panicucci, and M. Bendinelli. 1995. Serological reactivity and viral genotypes in hepatitis C virus infection. J. Clin. Microbiol. 33:204-211.
77. Makris, K., V. Kouvelis, I. Drakopoulos, E. Oikonomou, and A. Maniatis. 1995. Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second-and third-generation assays. Transfus. Med. 5:213-224.
78. Martinot-Peignoux, M., P. Marcellin, M. Pouteau, C. Castelnau, N. Boyer, M. Poliquin, C. Degott, I. Descombes, V. Le Breton, V. Milotova, J. P. Benhamou, and S. Erlinger. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to Interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056.
79. McFarlane, I. G., H. M. Smith, P. J. Johnson, G. P. Bray, D. Vergani, and R. Williams. 1990. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 335:754-757.
80. McHutchison, J. G., S. C. Gordon, E. R. Schiff, M. L. Shiffman, W. M. Lee, V. K. Rustgi, Z. D. Goodman, M. H. Ling, S. Cort, and J. K. Albrecht for the Hepatitis Interventional Therapy Group. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339:1485-1492.
81. McOmish, F., S. W. Chan, B. C. Dow, J. Gillon, W. D. Frame, R. J. Crawford, P. L. Yap, E. A. Follett, and P. Simmonds. 1993. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33:7-13.
82. McOmish, F., P. L. Yap, B. C. Dow, E. A. Follett, C. Seed, A. J. Keller, T. J. Cobain, T. Krusius, E. Kolho, R. Naukkarinen, C. Lin, C. Lai, S. Leong, G. A. Medgyesi, M. Héjjas, H. Kiyokawa, K. Fukada, T. Cuypers, A. A. Saeed, A. M. Al-Rasheed, M. Lin, and P. Simmonds. 1994. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J. Clin. Microbiol. 32:884-892.
83. Mellor, J., E. A. Walsh, L. E. Prescott, L. M. Jarvis, F. Davidson, P. L. Yap, and P. Simmonds. 1996. Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J. Clin. Microbiol. 34:417-423.
84. Missale, G., R. Bertoni, V. Lamonaca, A. Valli, M. Massari, C. Mori, M. G. Rumi, M. Houghton, F. Fiaccadori, and C. Ferrari. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Investig. 98:706-714.
85. Mondelli, M. U., A. Cerino, F. Bono, A. Cividini, A. Maccabruni, M. Aricó, A. Malfitano, G. Barbarini, V. Piazza, L. Minoli, and E. Silini. 1994. Hepatitis C virus (HCV) core serotypes in chronic HCV infection. J. Clin. Microbiol. 32:2523-2527.
86. Reference deleted.
87. Nakao, T., N. Enomoto, N. Takada, A. Takada, and T. Date. 1991. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J. Gen. Virol. 72:2105-2112.
88. Naoumov, N. V., S. Chokshi, E. Metivier, G. Maertens, P. J. Johnson, and R. Williams. 1997. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J. Hepatol. 27:331-336.
89. National Institutes of Health Consensus Development Conference Panel. 1997. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 26(Suppl. 1):2S-10S.
90. Nelson, D. R., and J. Y. N. Lau. 1998. Pathogenesis of chronic hepatitis C infection, p. 65-76. In R. F. Schinazi, J. P. Sommadossi, and H. C. Thomas (ed.), Therapies for viral hepatitis. International Medical Press, London, United Kingdom.
91. Nousbaum, J. B., S. Pol, B. Nalpas, P. Landais, P. Berthelot, C. Bréchot, and the Collaborative Study Group. 1995. Hepatitis C virus type 1b (II) infection in France and Italy. Ann. Intern. Med. 122:161-168.
92. Odeberg, J., Z. Yun, A. Sonnerborg, O. Weiland, and J. Lundeberg. 1998. Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment. J. Med. Virol. 56:33-38.
93. Ogata, N., H. J. Alter, R. H. Miller, and R. H. Purcell. 1991. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:3392-3396.
94. Okamoto, H., S. Kobata, H. Tokita, T. Inoue, G. D. Woodfield, P. V. Holland, B. A. Al-Knawy, O. Uzunalimoglu, Y. Miyakawa, and M. Mayumi. 1996. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene. J. Virol. Methods 57:31-45.
95. Okamoto, H., M. Kojima, M. Sakamoto, H. Iizuka, S. Hadiwandowo, S. Suwignyo, Y. Miyakawa, and M. Mayumi. 1994. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J. Gen. Virol. 75: 629-635.
96. Okamoto, H., K. Kurai, S. Okada, K. Yamamoto, H. Lizuka, T. Tanaka, S. Fukuda, F. Tsuda, and S. Mishiro. 1992. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 188:331-341.
97. Okamoto, H., S. Okada, Y. Sugiyama, K. Kurai, H. Iizuka, A. Machida, Y. Miyakawa, and M. Mayumi. 1991. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J. Gen. Virol. 72: 2697-2704.
98. Okamoto, H., Y. Sugiyama, S. Okada, K. Kurai, Y. Akahane, Y. Sugai, T. Tanaka, K. Sato, F. Tsuda, Y. Miyakawa, and M. Mayumi. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73:673-679.
99. Orito, E., M. Mizokami, K. Suzuki, K. Ohba, T. Ohno, M. Mori, K. Hayashi, K. Kato, S. Iino, and J. Y. Lau. 1995. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J. Med. Virol. 46:109-115.
100. Pageaux, G. P., J. Ducos, A. M. Mondain, V. Costes, M. C. Picot, P. F. Perrigault, J. Domergue, D. Larrey, and H. Michel. 1997. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection. Liver Transplant. Surg. 3:501-505.
101. Pawlotsky, J. M., L. Taskiris, F. Roudot-Thoraval, C. Pellet, L. Stuyver, J. Duval, and D. Dhumeaux. 1995. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J. Infect. Dis. 171:1607-1610.
102. Pistello, M., F. Maggi, L. Vatteroni, N. Cecconi, F. Panicucci, G. P. Bresci, L. Gambardella, M. Taddei, A. Bionda, M. Tuoni, and M. Bendinelli. 1994. Prevalence of hepatitis C virus genotypes in Italy. J. Clin. Microbiol. 32: 232-234.
103. Pol, S., V. Thiers, J. B. Nousbaum, C. Legendre, P. Berthelot, H. Kreis, and C. Brechot. 1995. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 108:581-583.
104. Power, J. P., E. Lawlor, F. Davidson, E. C. Holmes, P. L. Yap, and P. Simmonds. 1995. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 345:1211-1213.
105. Pozzato, G., M. Moretti, L. S. Croce, F. Sasso, S. Kaneko, M. Unoura, K. Kobayashi, M. Crovatto, G. Santini, and C. Tiribelli. 1995. Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains. J. Med. Virol. 45:445-450.
106. Reference deleted.
107. Qu, D., J. S. Li, L. Vitvitski, S. Mechai, F. Berby, S. P. Tong, F. Bailly, Q. S. Wang, J. L. Martin, and C. Trepo. 1994. Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II. J. Hepatol. 21:70-75.
108. Reference deleted.
109. Sakamoto, M., Y. Akahane, F. Tsuda, T. Tanaka, D. G. Woodfield, and H. Okamoto. 1994. Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J. Gen. Virol. 75:1761-1768.
110. Shimizu, Y. K., M. Hijikata, A. Iwamoto, H. J. Alter, R. H. Purcell, and H. Yoshikura. 1994. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68:1494-1500.
111. Shuhart, M. C., M. P. Bronner, D. R. Gretch, L. V. Thomassen, C. F. Wartelle, H. Tateyama, S. S. Emerson, J. D. Perkins, and R. L. Carithers, Jr. 1997. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 26:1646-1652.
112. Silini, E., F. Bono, A. Cividini, A. Cerino, S. Bruno, S. Rossi, G. Belloni, B. Brugnetti, E. Civardi, L. Salvaneschi, and M. U. Mondelli. 1995. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21:285-290.
113. Simmonds, P. 1995. Variability of hepatitis C virus. Hepatology 21:570-583.
114. Reference deleted.
115. Simmonds, P., E. C. Holmes, T. A. Cha, S. W. Chan, F. McOmish, B. Irvine, E. Beall, P. L. Yap, J. Kolberg, and M. S. Urdea. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74:2391-2399.
116. Simmonds, P., F. McOmish, P. L. Yap, S. W. Chan, C. K. Lin, G. Dusheiko, A. A. Saeed, and E. C. Holmes. 1993. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J. Gen. Virol. 74:661-668.
117. Simmonds, P., J. Mellor, A. Craxi, J. M. Sanchez-Tapias, A. Alberti, J. Prieto, M. Colombo, M. G. Rumi, O. Lo Iacano, S. Ampurdances-Mingall, X. Forns-Bernhardt, L. Chemello, M. P. Civeira, C. Frost, and G. Dusheiko. 1996. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J. Hepatol. 24:517-524.
118. Simmonds, P., J. Mellor, T. Sakuldamrongpanich, C. Nuchaprayoon, S. Tanprasert, E. C. Holmes, and D. B. Smith. 1996. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J. Gen. Virol. 77:3013-3024.
119. Simmonds, P., K. A. Rose, S. Graham, S. W. Chan, F. McOmish, B. C. Dow, E. A. Follett, P. L. Yap, and H. Marsden. 1993. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J. Clin. Microbiol. 31:1493-1503.
120. Smith, D. B., J. Mellor, L. M. Jarvis, F. Davidson, J. Kolberg, M. Urdea, P. L. Yap, P. Simmonds, and The International HCV Collaborative Study Group. 1995. Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. J. Gen. Virol. 76:1749-1761.
121. Smith, D. B., and P. Simmonds. 1997. Molecular epidemiology of hepatitis C virus. J. Gastroenterol. Hepatol. 12:522-527.
122. Songsivilai, S., D. Kanistanon, and T. Dharakul. 1998. A serotyping assay for hepatitis C virus in Southeast Asia. Clin. Diagn. Lab. Immunol. 5:737-739.
123. Stuyver, L., R. Rossau, A. Wyseur, M. Duhamel, B. Vanderborght, H. Van Heuverswyn, and G. Maertens. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74:1093-1102.
124. Takada, N., S. Takase, A. Takada, and T. Date. 1993. Differences in the hepatitis C virus genotypes in different countries. J. Hepatol. 17:277-283.
125. Takahashi, M., G. Yamada, R. Miyamoto, T. Doi, H. Endo, and T. Tsuji. 1993. Natural course of chronic hepatitis C. Am. J. Gastroenterol. 88:240-243.
126. Takamizawa, A., C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, and H. Okayama. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65:1105-1113.
127. Tokita, H., H. Okamoto, H. Iizuka, J. Kishimoto, F. Tsuda, L. A. Lesmana, Y. Miyakawa, and M. Mayumi. 1996. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J. Gen. Virol. 77:293-301.
128. Tokita, H., H. Okamoto, H. Iizuka, J. Kishimoto, F. Tsuda, Y. Miyakawa, and M. Mayumi. 1998. The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups. J. Gen. Virol. 79:1847-1857.
129. Tokita, H., H. Okamoto, F. Tsuda, P. Song, S. Nakata, T. Chosa, H. Iizuka, S. Mishiro, Y. Miyakawa, and M. Mayumi. 1994. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc. Natl. Acad. Sci. USA 91:11022-11026.
130. Tsukiyama-Kohara, K., K. Yamaguchi, N. Maki, Y. Ohta, K. Miki, M. Mizokami, K.-I. Ohba, S. Tanaka, N. Hattori, A. Nomoto, and M. Kohara. 1993. Antigenicities of Group I and II hepatitis C virus polypeptides -molecular basis of diagnosis. Virology 192:430-437.
131. Watson, J. P., A. M. Brind, C. E. Chapman, C. L. Bates, F. K. Gould, S. J. Johnson, A. D. Burt, J. Ferguson, P. Simmonds, and M. F. Bassendine. 1996. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut 38:269-276.
132. Weiland, O., Y. Y. Zhang, and A. Widell. 1993. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment. Scand. J. Infect. Dis. 25:25-30.
133. Weiner, A. J., M. M. Thaler, K. Crawford, K. Ching, J. Kansopon, D. Y. Chien, J. E. Hall, F. Hu, and M. Houghton. 1993. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J. Virol. 67:4365-4368.
134. Widell, A., S. Shev, S. Mansson, Y. Y. Zhang, U. Foberg, G. Norkrans, A. Fryden, O. Weiland, J. Kurkus, and E. Nordenfelt. 1994. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J. Med. Virol. 44:272-279.
135. Xavier, F., and J. Bukh. 1998. Methods for determining the hepatitis C genotype. Viral Hepatitis Rev. 4:1-19.
136. Yamada, M., S. Kakumu, K. Yoshioka, Y. Higashi, K. Tanaka, T. Ishikawa, and M. Takayanagi. 1994. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig. Dis. Sci. 39:234-239.
137. Yano, M., H. Yatsuhashi, O. Inoue, K. Inokuchi, and M. Koga. 1993. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 34(Suppl. 2):S13-S16.
138. Zein, N. N. 1997. Vertical transmission of hepatitis C: to screen or not to screen. J. Pediatr. 130:859-861. (Editorial.)
139. Reference deleted.
140. Zein, N. N., J. J. Germer, N. K. Wendt, C. M. Schimek, J. N. Thorvilson, P. S. Mitchell, and D. H. Persing. 1997. Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes. J. Clin. Microbiol. 35:311-312.
141. Reference deleted.
142. Zein, N. N., and D. H. Persing. 1996. Hepatitis C genotypes: current trends and future implications. Mayo Clin. Proc. 71:458-462.
143. Zein, N. N., J. J. Poterucha, J. B. Gross, Jr., R. H. Wiesner, T. M. Therneau, A. A. Gossard, N. K. Wendt, P. S. Mitchell, J. J. Germer, and D. H. Persing. 1996. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am. J. Gastroenterol. 91:2560-2562.
144. Zein, N. N., and J. Rakela. 1995. Interferon therapy in hepatitis C. Semin. Gastrointest. Dis. 6:46-53.
145. Zein, N. N., J. Rakela, E. L. Krawitt, K. R. Reddy, T. Tominaga, D. H. Persing, and the Collaborative Study Group. 1996. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann. Intern. Med. 125:634-639.
146. Zein, N. N., J. Rakela, and D. H. Persing. 1995. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clin. Proc. 70:449-452.
147. Zein, N. N., J. Rakela, J. J. Poterucha, J. L. Steers, R. H. Wiesner, and D. H. Persing. 1995. Hepatitis C genotypes in liver transplant recipients:
148. Zhou, S., N. A. Terrault, L. Ferrell, J. A. Hahn, J. Y. Lau, P. Simmonds, J. P. Roberts, J. R. Lake, N. L. Ascher, and T. L. Wright. 1996. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 24:1041-1046.
149. Zibert, A., E. Schreier, and M. Roggendorf. 1995. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-651.